XDA Developers on MSN

5 reasons a basic Arduino board is the best addition to your home lab

A basic Arduino board adds creativity, flexibility, and interactivity to your home lab. It costs little but opens countless ...

ESGold Confirms Final Processing Methodology at Montauban as Construction Nears Completion

Metallurgical work validates processing approach for railway tailings; construction progressing ahead of schedule and ...
DIGITIMES

Shennan Circuits and China’s PCB sector gear up for the space economy

As China accelerates its ambitions in low-Earth-orbit (LEO) communications, the country's push for homegrown satellite ...
VoxelMatters

Researchers 3D print circuit board that can be dissolved in water

Researchers 3D print circuit board that can be dissolved in water. DissolvPCB can be created using a standard FDM system, PVA ...
WHBL

City to Appeal Court Decision Reinstating Lt. Adams With Back Pay

City leaders will be appealing a decision in Sheboygan County Circuit Court that found in favor of Sheboygan Police ...
Kauppalehti

Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief ...

Series A led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates Foundation and Alexandria Venture Investments NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Nilo ...
WTEN

Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief ...

NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Nilo Therapeutics, a biotechnology company harnessing neural circuits to restore immune homeostasis in disease, launched today with a $101 million Series A ...
FierceBiotech

Immunology biotech Nilo launches with $101M and mission to harness neural circuits

Nilo Therapeutics has launched with $101 million in series A funds to drive its ambition to harness neural circuits to restore immune homeostasis. The New York-headquartered company was founded by a ...
Mena FN

Nilo Therapeutics Launches With $101 Million Series A Financing To Advance A New Class Of Medicines Targeting Neural Circuits In Immune Disease And Appoints Kim Seth As Chief ...

(MENAFN- GlobeNewsWire - Nasdaq) Series A led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates Foundation and Alexandria Venture Investments NEW YORK, Oct. 08, 2025 ...